Selected research
Industry Research
Retinoic Acid Receptor Gamma Industry Research Report 2026
Market perspective
The global Retinoic Acid Receptor Gamma market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Retinoic Acid Receptor Gamma is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Retinoic Acid Receptor Gamma is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Retinoic Acid Receptor Gamma is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Retinoic Acid Receptor Gamma include Valeant Pharmaceuticals International Inc, Sol-Gel Technologies Ltd, Promius Pharma LLC, Phosphagenics Ltd, Lee's Pharmaceutical Holdings Ltd, Galderma SA, Clementia Pharmaceuticals Inc, Boehringer Ingelheim GmbH and 3SBio Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Retinoic Acid Receptor Gamma market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Retinoic Acid Receptor Gamma Market by Company
Valeant Pharmaceuticals International Inc
Sol-Gel Technologies Ltd
Promius Pharma LLC
Phosphagenics Ltd
Lee's Pharmaceutical Holdings Ltd
Galderma SA
Clementia Pharmaceuticals Inc
Boehringer Ingelheim GmbH
3SBio Inc
Retinoic Acid Receptor Gamma Segment by Type
Tretinoin
Palovarotene
Bexarotene
Alitretinoin
Others
Retinoic Acid Receptor Gamma Segment by Application
Musculoskeletal Disorder
Immunology
Dernatology
Ophthalmology
Others
Retinoic Acid Receptor Gamma Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Retinoic Acid Receptor Gamma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Retinoic Acid Receptor Gamma and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Retinoic Acid Receptor Gamma.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Retinoic Acid Receptor Gamma manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Retinoic Acid Receptor Gamma by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Retinoic Acid Receptor Gamma in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tretinoin
- Palovarotene
- Bexarotene
- Alitretinoin
- Others
Applications
- Musculoskeletal Disorder
- Immunology
- Dernatology
- Ophthalmology
- Others
Companies covered
- Valeant Pharmaceuticals International Inc
- Sol-Gel Technologies Ltd
- Promius Pharma LLC
- Phosphagenics Ltd
- Lee's Pharmaceutical Holdings Ltd
- Galderma SA
- Clementia Pharmaceuticals Inc
- Boehringer Ingelheim GmbH
- 3SBio Inc
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Retinoic Acid Receptor Gamma Market Size (2021-2032)
- 2.2.2 Global Retinoic Acid Receptor Gamma Sales (2021-2032)
- 2.2.3 Global Retinoic Acid Receptor Gamma Market Average Price (2021-2032)
- 2.3 Retinoic Acid Receptor Gamma by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tretinoin
- 2.3.3 Palovarotene
- 2.3.4 Bexarotene
- 2.3.5 Alitretinoin
- 2.3.6 Others
- 2.4 Retinoic Acid Receptor Gamma by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Musculoskeletal Disorder
- 2.4.3 Immunology
- 2.4.4 Dernatology
- 2.4.5 Ophthalmology
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Retinoic Acid Receptor Gamma Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Retinoic Acid Receptor Gamma Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Retinoic Acid Receptor Gamma Revenue of Manufacturers (2021-2026)
- 3.4 Global Retinoic Acid Receptor Gamma Average Price by Manufacturers (2021-2026)
- 3.5 Global Retinoic Acid Receptor Gamma Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Retinoic Acid Receptor Gamma, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Retinoic Acid Receptor Gamma, Product Type & Application
- 3.8 Global Manufacturers of Retinoic Acid Receptor Gamma, Established Date
- 3.9 Global Retinoic Acid Receptor Gamma Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Valeant Pharmaceuticals International Inc
- 4.1.1 Valeant Pharmaceuticals International Inc Company Information
- 4.1.2 Valeant Pharmaceuticals International Inc Business Overview
- 4.1.3 Valeant Pharmaceuticals International Inc Retinoic Acid Receptor Gamma Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Valeant Pharmaceuticals International Inc Retinoic Acid Receptor Gamma Product Portfolio
- 4.1.5 Valeant Pharmaceuticals International Inc Recent Developments
- 4.2 Sol-Gel Technologies Ltd
- 4.2.1 Sol-Gel Technologies Ltd Company Information
- 4.2.2 Sol-Gel Technologies Ltd Business Overview
- 4.2.3 Sol-Gel Technologies Ltd Retinoic Acid Receptor Gamma Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sol-Gel Technologies Ltd Retinoic Acid Receptor Gamma Product Portfolio
- 4.2.5 Sol-Gel Technologies Ltd Recent Developments
- 4.3 Promius Pharma LLC
- 4.3.1 Promius Pharma LLC Company Information
- 4.3.2 Promius Pharma LLC Business Overview
- 4.3.3 Promius Pharma LLC Retinoic Acid Receptor Gamma Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Promius Pharma LLC Retinoic Acid Receptor Gamma Product Portfolio
- 4.3.5 Promius Pharma LLC Recent Developments
- 4.4 Phosphagenics Ltd
- 4.4.1 Phosphagenics Ltd Company Information
- 4.4.2 Phosphagenics Ltd Business Overview
- 4.4.3 Phosphagenics Ltd Retinoic Acid Receptor Gamma Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Phosphagenics Ltd Retinoic Acid Receptor Gamma Product Portfolio
- 4.4.5 Phosphagenics Ltd Recent Developments
- 4.5 Lee's Pharmaceutical Holdings Ltd
- 4.5.1 Lee's Pharmaceutical Holdings Ltd Company Information
- 4.5.2 Lee's Pharmaceutical Holdings Ltd Business Overview
- 4.5.3 Lee's Pharmaceutical Holdings Ltd Retinoic Acid Receptor Gamma Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Lee's Pharmaceutical Holdings Ltd Retinoic Acid Receptor Gamma Product Portfolio
- 4.5.5 Lee's Pharmaceutical Holdings Ltd Recent Developments
- 4.6 Galderma SA
- 4.6.1 Galderma SA Company Information
- 4.6.2 Galderma SA Business Overview
- 4.6.3 Galderma SA Retinoic Acid Receptor Gamma Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Galderma SA Retinoic Acid Receptor Gamma Product Portfolio
- 4.6.5 Galderma SA Recent Developments
- 4.7 Clementia Pharmaceuticals Inc
- 4.7.1 Clementia Pharmaceuticals Inc Company Information
- 4.7.2 Clementia Pharmaceuticals Inc Business Overview
- 4.7.3 Clementia Pharmaceuticals Inc Retinoic Acid Receptor Gamma Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Clementia Pharmaceuticals Inc Retinoic Acid Receptor Gamma Product Portfolio
- 4.7.5 Clementia Pharmaceuticals Inc Recent Developments
- 4.8 Boehringer Ingelheim GmbH
- 4.8.1 Boehringer Ingelheim GmbH Company Information
- 4.8.2 Boehringer Ingelheim GmbH Business Overview
- 4.8.3 Boehringer Ingelheim GmbH Retinoic Acid Receptor Gamma Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Boehringer Ingelheim GmbH Retinoic Acid Receptor Gamma Product Portfolio
- 4.8.5 Boehringer Ingelheim GmbH Recent Developments
- 4.9 3SBio Inc
- 4.9.1 3SBio Inc Company Information
- 4.9.2 3SBio Inc Business Overview
- 4.9.3 3SBio Inc Retinoic Acid Receptor Gamma Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 3SBio Inc Retinoic Acid Receptor Gamma Product Portfolio
- 4.9.5 3SBio Inc Recent Developments
5 Global Retinoic Acid Receptor Gamma Market Scenario by Region
- 5.1 Global Retinoic Acid Receptor Gamma Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Retinoic Acid Receptor Gamma Sales by Region: 2021-2032
- 5.2.1 Global Retinoic Acid Receptor Gamma Sales by Region: 2021-2026
- 5.2.2 Global Retinoic Acid Receptor Gamma Sales by Region: 2027-2032
- 5.3 Global Retinoic Acid Receptor Gamma Revenue by Region: 2021-2032
- 5.3.1 Global Retinoic Acid Receptor Gamma Revenue by Region: 2021-2026
- 5.3.2 Global Retinoic Acid Receptor Gamma Revenue by Region: 2027-2032
- 5.4 North America Retinoic Acid Receptor Gamma Market Facts & Figures by Country
- 5.4.1 North America Retinoic Acid Receptor Gamma Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Retinoic Acid Receptor Gamma Sales by Country (2021-2032)
- 5.4.3 North America Retinoic Acid Receptor Gamma Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Retinoic Acid Receptor Gamma Market Facts & Figures by Country
- 5.5.1 Europe Retinoic Acid Receptor Gamma Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Retinoic Acid Receptor Gamma Sales by Country (2021-2032)
- 5.5.3 Europe Retinoic Acid Receptor Gamma Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Retinoic Acid Receptor Gamma Market Facts & Figures by Country
- 5.6.1 Asia Pacific Retinoic Acid Receptor Gamma Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Retinoic Acid Receptor Gamma Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Retinoic Acid Receptor Gamma Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Retinoic Acid Receptor Gamma Market Facts & Figures by Country
- 5.7.1 South America Retinoic Acid Receptor Gamma Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Retinoic Acid Receptor Gamma Sales by Country (2021-2032)
- 5.7.3 South America Retinoic Acid Receptor Gamma Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Retinoic Acid Receptor Gamma Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Retinoic Acid Receptor Gamma Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Retinoic Acid Receptor Gamma Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Retinoic Acid Receptor Gamma Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Retinoic Acid Receptor Gamma Sales by Type (2021-2032)
- 6.1.1 Global Retinoic Acid Receptor Gamma Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Retinoic Acid Receptor Gamma Sales Market Share by Type (2021-2032)
- 6.2 Global Retinoic Acid Receptor Gamma Revenue by Type (2021-2032)
- 6.2.1 Global Retinoic Acid Receptor Gamma Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Retinoic Acid Receptor Gamma Revenue Market Share by Type (2021-2032)
- 6.3 Global Retinoic Acid Receptor Gamma Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Retinoic Acid Receptor Gamma Sales by Application (2021-2032)
- 7.1.1 Global Retinoic Acid Receptor Gamma Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Retinoic Acid Receptor Gamma Sales Market Share by Application (2021-2032)
- 7.2 Global Retinoic Acid Receptor Gamma Revenue by Application (2021-2032)
- 7.2.1 Global Retinoic Acid Receptor Gamma Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Retinoic Acid Receptor Gamma Revenue Market Share by Application (2021-2032)
- 7.3 Global Retinoic Acid Receptor Gamma Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Retinoic Acid Receptor Gamma Value Chain Analysis
- 8.1.1 Retinoic Acid Receptor Gamma Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Retinoic Acid Receptor Gamma Production Mode & Process
- 8.2 Retinoic Acid Receptor Gamma Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Retinoic Acid Receptor Gamma Distributors
- 8.2.3 Retinoic Acid Receptor Gamma Customers
9 Global Retinoic Acid Receptor Gamma Analyzing Market Dynamics
- 9.1 Retinoic Acid Receptor Gamma Industry Trends
- 9.2 Retinoic Acid Receptor Gamma Industry Drivers
- 9.3 Retinoic Acid Receptor Gamma Industry Opportunities and Challenges
- 9.4 Retinoic Acid Receptor Gamma Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst